Method for screening drug and chemical effects in laboratory rats using computerized quantitative...

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Quantitative electroencephalography (qEEG) is a valuable tool for assessing neurological function.
• Current methods often require anesthesia, which can confound results in drug testing.
• There is a need for non-invasive qEEG methods suitable for regulatory toxicology.

Purpose of the Study:

• To develop and validate a minimally-invasive, non-anesthetic qEEG method for regulatory testing in rats.
• To assess the qEEG changes induced by cholinesterase inhibition using physostigmine.
• To evaluate the qEEG alterations caused by M2 autoreceptor agonist oxotremorine.

Main Methods:

• Developed a non-anesthetic qEEG technique in Fischer 344 and Sprague-Dawley rats.
• Administered physostigmine (0.05-1.0 mg/kg) to induce varying levels of cholinesterase inhibition.
• Administered oxotremorine (0.05-0.2 mg/kg) to assess M2 autoreceptor agonist effects.

Main Results:

• Physostigmine administration correlated with increased total power and amplitude changes, decreased alpha/beta, increased delta, and a left-shift in spectral-edge frequency.
• Oxotremorine administration resulted in increased beta, decreased alpha, and a right-shift in spectral-edge frequency.
• Observed qEEG changes correlated with known muscarinic effects of the tested compounds.

Conclusions:

• The developed minimally-invasive qEEG method is reliable for regulatory testing of drugs and chemicals.
• This technique effectively captures receptor-specific and general muscarinic effects.
• Validated qEEG as a tool for analyzing cholinergic compound agonist and antagonist activities.